sorafenib has been researched along with h 1152 in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (h 1152) | Trials (h 1152) | Recent Studies (post-2010) (h 1152) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 10 | 0 | 4 |
| Protein | Taxonomy | sorafenib (IC50) | h 1152 (IC50) |
|---|---|---|---|
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
| Chain I, cAMP-dependent protein kinase inhibitor alpha | synthetic construct | 0.1035 | |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | 0.1035 | |
| Chain I, cAMP-dependent protein kinase inhibitor alpha | synthetic construct | 0.1035 | |
| Rho-associated protein kinase 2 | Homo sapiens (human) | 0.0097 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.3254 | |
| Rho-associated protein kinase 1 | Homo sapiens (human) | 0.005 | |
| Rho-associated protein kinase 2 | Bos taurus (cattle) | 0.3254 | |
| Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | 0.244 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giranda, VL; Johnson, EF; Luo, Y; Stewart, KD; Woods, KW | 1 |
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
2 other study(ies) available for sorafenib and h 1152
| Article | Year |
|---|---|
Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Androstadienes; Binding Sites; Cell Cycle Proteins; Humans; Models, Molecular; Molecular Sequence Data; Peptide Library; Polo-Like Kinase 1; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Substrate Specificity; Wortmannin | 2007 |
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |